Takahashi, Y., Kida, K., Nishimura, M., Terata, K., Futamura, M., Yoshida, A., Shien, T., Ueno, T., Takano, T. (2025). OPERETTA: A phase II study evaluating neoadjuvant and adjuvant olaparib plus pembrolizumab following platinum-based chemotherapy plus pembrolizumab for germline BRCA mutated triple negative breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps632